An Inducible HIV Type 1 gp41 HR-2 Peptide-Binding Site on HIV Type 1 Envelope gp120-Reference-Cited by-同舟云学术

An Inducible HIV Type 1 gp41 HR-2 Peptide-Binding Site on HIV Type 1 Envelope gp120

Published:2004-08 Issue:8 Volume:20 Page:836-845
ISSN:0889-2229
Container-title:AIDS Research and Human Retroviruses
language:en
Short-container-title:AIDS Research and Human Retroviruses

Author:

Alam S. Munir¹,Paleos Casey A.²,Liao Hua-Xin¹,Scearce Richard³,Robinson James⁴,Haynes Barton F.⁵

Affiliation:

1. Department of Medicine, Duke University School of Medicine, Durham, North Carolina 27707; Duke Center for AIDS Research and the Human Vaccine Institute, Duke University School of Medicine, Durham, North Carolina 27707.

2. Department of Medicine, Duke University School of Medicine, Durham, North Carolina 27707.

3. Department of Medicine, Duke University School of Medicine, Durham, North Carolina 27707Duke Center for AIDS Research and the Human Vaccine Institute, Duke University School of Medicine, Durham, North Carolina 27707.

4. Tulane University, New Orleans, Louisiana 70118.

5. Department of Medicine, Duke University School of Medicine, Durham, North Carolina 27707; Duke Center for AIDS Research and the Human Vaccine Institute, Duke University School of Medicine, Durham, North Carolina 27707; Department of Immunology, Duke University School of Medicine, Durham, North Carolina 27707.

Publisher

Mary Ann Liebert Inc

Subject

Infectious Diseases,Virology,Immunology

Link

http://www.liebertpub.com/doi/pdf/10.1089/0889222041725181

Reference20 articles.

1. Core Structure of gp41 from the HIV Envelope Glycoprotein

2. A synthetic peptide inhibitor of human immunodeficiency virus replication: correlation between solution structure and viral inhibition.

3. Potent suppression of HIV-1 replication in humans by T-20, a peptide inhibitor of gp41-mediated virus entry

4. Determinants of Human Immunodeficiency Virus Type 1 Resistance to gp41-Derived Inhibitory Peptides

5. Peptides corresponding to a predictive alpha-helical domain of human immunodeficiency virus type 1 gp41 are potent inhibitors of virus infection.

Cited by 41 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Peptide Drugs: Current Status and it's Applications in the Treatment of Various Diseases;Current Drug Research Reviews;2024-11

2. Natural Variation in HIV-1 Entry Kinetics Map to Specific Residues and Reveal an Interdependence Between Attachment and Fusion;2024-06-25

3. In Vitro Selection and Characterization of HIV-1 Variants with Increased Resistance to LP-40, Enfuvirtide-Based Lipopeptide Inhibitor;International Journal of Molecular Sciences;2022-06-14

4. The Tryptophan-Rich Motif of HIV-1 gp41 Can Interact with the N-Terminal Deep Pocket Site: New Insights into the Structure and Function of gp41 and Its Inhibitors;Journal of Virology;2019-12-12

5. Massively Parallel Profiling of HIV-1 Resistance to the Fusion Inhibitor Enfuvirtide;Viruses;2019-05-15